TCRX · CIK 0001783328 · operating
TScan Therapeutics, Inc. (TCRX) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $63 million, TScan Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.05, down 0.94% today, with a 52-week range of $0.88–$2.57.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.14 | $-1.14 | +16.2% | |
| 2023 | $-1.36 | $-1.36 | +50.5% | |
| 2022 | $-2.75 | $-2.75 | — | |
| 2021 | — | — | — |